This document contains a drug study for a patient named JN who was admitted on August 7, 2014 for pulmonary tuberculosis (PTB). The drug cefuroxime is prescribed to treat the patient's infection. Cefuroxime is a second-generation cephalosporin antibiotic that works by binding to bacterial cell walls and causing cell death. It is prescribed for respiratory, skin, bone, joint, urinary, and gynecological infections. The document outlines the dosage, effects, contraindications, nursing responsibilities, and patient teaching for cefuroxime administration and monitoring.
This document contains a drug study for a patient named JN who was admitted on August 7, 2014 for pulmonary tuberculosis (PTB). The drug cefuroxime is prescribed to treat the patient's infection. Cefuroxime is a second-generation cephalosporin antibiotic that works by binding to bacterial cell walls and causing cell death. It is prescribed for respiratory, skin, bone, joint, urinary, and gynecological infections. The document outlines the dosage, effects, contraindications, nursing responsibilities, and patient teaching for cefuroxime administration and monitoring.
This document contains a drug study for a patient named JN who was admitted on August 7, 2014 for pulmonary tuberculosis (PTB). The drug cefuroxime is prescribed to treat the patient's infection. Cefuroxime is a second-generation cephalosporin antibiotic that works by binding to bacterial cell walls and causing cell death. It is prescribed for respiratory, skin, bone, joint, urinary, and gynecological infections. The document outlines the dosage, effects, contraindications, nursing responsibilities, and patient teaching for cefuroxime administration and monitoring.
This document contains a drug study for a patient named JN who was admitted on August 7, 2014 for pulmonary tuberculosis (PTB). The drug cefuroxime is prescribed to treat the patient's infection. Cefuroxime is a second-generation cephalosporin antibiotic that works by binding to bacterial cell walls and causing cell death. It is prescribed for respiratory, skin, bone, joint, urinary, and gynecological infections. The document outlines the dosage, effects, contraindications, nursing responsibilities, and patient teaching for cefuroxime administration and monitoring.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 2
Republic of the Philippines
CAVITE STATE UNIVERSITY
(CvSU) Don Severino Delas Alas Campus Indang, Cavite (046) 4150-010 / 4150-011 (046) 4150-012
DRUG STUDY NAME OF PATIENT: JN DATE OF ADMISSION: AUGUST 7, 2014 AGE: 33 YEARS OLD DIAGNOSIS: PTB SEX: FEMALE Drug Features Mechanism of Action Indication
Contraindication
Effects Nursing Responsibilities Generic Name: Cefuroxime Brand Name: none Classification: anti-infectives Sub Classification: second-generation cephalosporins Dosage: 500 mg 1 tab Route: PO Frequency: BID Form: Film coated tablet Binds to bacterial cell wall membrane, causing cell death. Therapeutic Effects: Bactericidal action against susceptible bacteria. Spectrum: Similar to that of first-generation cephalosporins but has increased activity against several other gram-negative pathogens including: Haemophilus Treatment of: Respiratory tract infections, Skin and skin structure infections, Bone and joint infections (IV), Urinary tract infections, Gynecological infections, Septicemia (IV), Otitis media (PO), Meningitis (IV), Lyme disease (PO). Perioperative prophylaxis (IV). Contraindicated in: Hypersensitivity to cephalosporins; Serious hypersensitivity to penicillins. Use Cautiously in: Renal impairment (dose reduction/increase d dosing interval recommended if CCr 20 mL/min); History of GI disease, especially colitis; Geriatric patients (dose adjustment may be required due to Side Effects &Adverse Effects CNS: SEIZURES (HIGH DOSES). GI: PSEUDOMEMBRANOUS COLITIS, diarrhea, nausea, vomiting, cramps. Derm: rashes, urticaria, diaper dermatitis. Hemat: bleeding, eosinophilia, hemolytic anemia, leukopenia. Local: pain at IM site, phlebitis at IV site. Misc: ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS, superinfection. Check for doctors order Carefully read product packaging to note strength of solution, dosage/ route of administration. Observe 10 Rs in medicine administration Assessment: Assess for infection (vital signs; appearance of wound, sputum, urine, and stool; WBC) at beginning of and throughout therapy. Before initiating therapy, obtain a history to determine previous use of and reactions to penicillins or cephalosporins. Persons with a negative history of penicillin sensitivity may still have an allergic response. Obtain specimens for culture and sensitivity before initiating therapy. First dose may be given before receiving results. Observe patient for signs and symptoms of anaphylaxis (rash, pruritus, laryngeal edema, wheezing). Discontinue the drug and notify health care professional immediately if these symptoms occur. Keep epinephrine, an antihistamine, and resuscitation equipment close by in the event of an anaphylactic reaction.
influenzae (including - lactamase- producing strains), Haemophilus parainfluenzae, Escherichia coli, Klebsiella pneumoniae, Neisseria , Proteus, Moraxella catarrhalis, Borrelia burgdorferi. Not active against methicillin- resistant staphylococci or enterococci. age-related in renal function); Pregnancy and lactation (has been used safely). Monitor bowel function. Diarrhea, abdominal cramping, fever, and bloody stools should be reported to health care professional promptly as a sign of pseudomembranous colitis. May begin up to several weeks following cessation of therapy. Lab Test Considerations: May cause positive results for Coombs' test. May cause serum AST, ALT, alkaline phosphatase, bilirubin, LDH, BUN, and creatinine. May rarely cause leukopenia, neutropenia, and eosinophilia. Patient/Family Teaching: Instruct patient to take medication around the clock at evenly spaced times and to finish the medication completely, even if feeling better. Missed doses should be taken as soon as possible unless almost time for next dose; do not double doses. Advise patient that sharing of this medication may be dangerous. Pedi: Tell parents or cargeivers to use calibrated measuring device with liquid preparations. Advise patient to report signs of superinfection (furry overgrowth on the tongue, vaginal itching or discharge, loose or foul-smelling stools) and allergy. Instruct patient to notify health care professional if fever and diarrhea develop, especially if stool contains blood, pus, or mucus. Advise patient not to treat diarrhea without consulting health care professional. SUBMITTED BY: ANGELICA CASSANDRA P. VILLENA CLINICAL INSTRUCTOR: EDERLYN P. DESTURA RN, MAN YEAR & SEC. GRP: BSN 3 1 GRP 1 DATE: AUGUST 15, 2014